Anticipating gemcitabine-related severe/lethal toxicities: A feasibility study

14652 Background: Gemcitabine is an antimetabolite drug extensively used for treating solid tumors in adults. Gemcitabine pharmacokinetics is altered by Cytidine Deaminase (CDA) gene polymorphism, ...